These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8634919)

  • 41. [Principles and rules of the use of nitrates].
    Garcia Moll M
    Ann Cardiol Angeiol (Paris); 1997; 46(7):399-405. PubMed ID: 9452773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjuvant therapy of chronic refractory cardiac failure with oral hydralazine and isosorbide dinitrate.
    Kothiala A; Ramnani K; Patel HR; Mehta NC; Shah CP
    J Assoc Physicians India; 1983 Jun; 31(6):343-6. PubMed ID: 6654793
    [No Abstract]   [Full Text] [Related]  

  • 43. Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation.
    Szöcs K; Lassègue B; Wenzel P; Wendt M; Daiber A; Oelze M; Meinertz T; Münzel T; Baldus S
    J Mol Cell Cardiol; 2007 Jun; 42(6):1111-8. PubMed ID: 17493633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
    Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
    Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nitrate resistance and tolerance: potential limitations in the treatment of congestive heart failure.
    Elkayam U; Mehra A; Shotan A; Ostrzega E
    Am J Cardiol; 1992 Sep; 70(8):98B-104B. PubMed ID: 1529933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Nitroglycerin preparations. Effect and tolerance].
    Kjøller-Hansen L; Boesgaard S; Laursen JB; Poulsen HE; Aldershvile J
    Ugeskr Laeger; 1994 Jun; 156(24):3621-5. PubMed ID: 8066882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapy of angina pectoris with long-acting nitrates: which agent and when?
    Abrams J
    Can J Cardiol; 1996 May; 12 Suppl C():9C-16C. PubMed ID: 8634922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin E deficiency accelerates nitrate tolerance via a decrease in cardiac P450 expression and increased oxidative stress.
    Minamiyama Y; Takemura S; Hai S; Suehiro S; Okada S
    Free Radic Biol Med; 2006 Mar; 40(5):808-16. PubMed ID: 16520233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Long-term use of vasodilators in patients with congestive cardiomyopathy (author's transl)].
    Nishijima H; Yasuda H; Itoh K; Murakami R; Nakagawa T; Kudo T
    Hokkaido Igaku Zasshi; 1980 Jan; 55(1):7-13. PubMed ID: 7409730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure.
    Chirkov YY; De Sciscio M; Sverdlov AL; Leslie S; Sage PR; Horowitz JD
    Cardiovasc Drugs Ther; 2010 Apr; 24(2):131-7. PubMed ID: 20490904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous nitroglycerin tolerance in patients with ischemic cardiomyopathy and congestive heart failure.
    Earl GL; Stanek EJ; Spinler SA
    Pharmacotherapy; 1998; 18(1):203-9. PubMed ID: 9469695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Intravenous molsidomine administration in heart failure. Part II: Comparison with nitroglycerin and effectiveness in nitrate tolerance].
    Störk T; Möckel M; Danne O; Müller R; Eichstädt H; Hochrein H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():50-3. PubMed ID: 7968904
    [No Abstract]   [Full Text] [Related]  

  • 54. [Special place of PETN among nitrates. No tolerance development, fewer headaches].
    Münzel T
    MMW Fortschr Med; 2008 Jan; 150(1-2):41. PubMed ID: 18300643
    [No Abstract]   [Full Text] [Related]  

  • 55. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
    Kośmicki M; Sadowski Z; Szwed H; Kowalik I
    Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of lipoic acid in prevention of nitroglycerin tolerance.
    Dudek M; Bednarski M; Bilska A; Iciek M; Sokołowska-Jezewicz M; Filipek B; Włodek L
    Eur J Pharmacol; 2008 Sep; 591(1-3):203-10. PubMed ID: 18616939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Controlled clinical studies of tolerance development and dosing problems in nitrate therapy].
    Abshagen U
    Herz; 1996 Jun; 21 Suppl 1():23-30. PubMed ID: 8767921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral nitrate preparations: an update.
    Bomber JW; De Tullio PL
    Am Fam Physician; 1995 Dec; 52(8):2331-7. PubMed ID: 7484725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of vasodilator therapy in congestive heart failure. Effects on mortality.
    Greenberg B
    Cardiol Clin; 1994 Feb; 12(1):87-99. PubMed ID: 8181028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Lack of tolerance development with low dose nitrate administration in acute myocardial infarct].
    Meissner A; Petermann W; Fanous Z; Simon R; Schulte HM
    Z Kardiol; 1989; 78 Suppl 2():130-2; discussion 142-4. PubMed ID: 2511686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.